Characteristics

Pre-Option B+ Cohort (N = 102)

Option B+ Cohort (N = 190)

P-value

Mean age (IQR)

29 (25 - 32)

27 (24 - 31)

0.002

Median baseline CD4 count (IQR)^{^}

231 (165 - 269)

558 (493 - 700)

<0.001

WHO clinical stage^*

Stage 1 or 2, N (%)

89 (88.1)

188 (99.0)

<0.001

Stage 3 or 4, N (%)

12 (11.9)

2 (1.1)

<0.001

Opportunistic infection at ART initiation

Kaposi’s sarcoma, N (%)

3 (2.9)

0

0.04

Active tuberculosis, N (%)

1 (1.0)

0

0.35